Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>Sarcopenia is a well-known risk factor for inferior cancer outcomes, but the identification of patients at risk remains challenging. A new sarcopenia index (SI), defined as serum creatinine (Cr) × cystatin C (CysC)-based glomerular filtration rate (eGFR<sub>CysC</sub>), has been reported to be an objective surrogate marker for sarcopenia. We aimed to assess whether the SI is associated with sarcopenia and cancer-related fatigue (CRF) in advanced cancer patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>A total of 182 patients with different types of cancer (cancer stages III/IV; mean age 55.1 ± 11.1 years) were enrolled in this cross-sectional study. Sarcopenia was defined as the presence of both low muscle mass and low muscle strength. The cross-sectional area of skeletal muscle mass (SMA) at the third lumbar spine was estimated by computed tomography (CT). Low muscle mass was defined as a skeletal muscle index (SMA/height2) less than 34.9 cm2/m2 for females and 40.8 cm2/m2 for males. Low muscle strength was determined by handgrip strength (HGS) according to the cutoffs of the Asian Working Group for Sarcopenia (< 18 kg for women and < 26 kg for men). CRF was measured by the Brief Fatigue Inventory (BFI). The associations between SI with both sarcopenia and CRF were investigated.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The prevalence of sarcopenia was 27.5%. The SI was significantly lower in both the sarcopenia and severe fatigue groups. The associations between SI and SMA (<em>r</em> = 0.365; <em>P</em> < 0.001), skeletal muscle index (SMI) (<em>r</em> = 0.340; <em>P</em> < 0.001) and HGS (<em>r</em> = 0.414; <em>P</em> < 0.001) were stronger than the associations between the serum creatinine/ cystatin C (Cr/CysC) ratio and SMA (<em>r</em> = 0.299; <em>P</em> <0.001), SMI (<em>r</em> = 0.269; <em>P</em> < 0.001) and HGS (<em>r</em> = 0.364; <em>P</em> < 0.001). In addition, a decrease in the SI was associated with a higher likelihood of sarcopenia [odds ratio per 10-unit, 1.09; 95% confidence interval (CI), 1.02–1.16] after adjusting for potential confounding factors. However, there was only a weak correlation between the SI and BFI score (<em>r</em> = -0.161, <em>P</em> = 0.045).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>The SI might be a useful objective tool for assessing sarcopenia in advanced cancer patients. Further studies are warranted to extend our findings.</p>

Serum Creatinine to Cystatin C Ratio and Cognitive Function among Middle-Aged and Older Adults in China

Sex Differences in the Relationship of Serum Creatinine to Cystatin C Ratio and Depressive Symptoms among Middle-Aged and Older Adults in China

Association between sarcopenia and cognitive function in older Chinese adults: Evidence from the China health and retirement longitudinal study

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients

Cia_a_351068 211..221

Lower serum creatinine to cystatin C ratio associated with increased incidence of frailty in community-dwelling elderly men but not in elderly women

Prevalence of sarcopenia in multi ethnics adults and the association with cognitive impairment: findings from West-China Health and Aging Trend Study

The Association Between Sarcopenia and Cognitive Performance : Data from the National Health and Nutrition Examination Surveys 1999 to 2002

A Combination of Serum Biomarkers in Elderly Patients with Sarcopenia: A Cross-Sectional Observational Study

Association of Performance on Multiple Cognitive Domains with Sarcopenia among Middle-Aged and Older Adults

Serum creatinine/cystatin C ratio is a predictor of all-cause mortality for older adults over 80 years

Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease

A New Index Based on Serum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density

Relationship Between Social Support, Sarcopenia, and Cognitive Impairment in Chinese Community-Dwelling Older Adults

A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer

Sex differences in the association between sarcopenia index and sarcopenia: a cross-sectional study from a Chinese community-based population

Multidimensional Assessment of Sarcopenia and Sarcopenic Obesity in Geriatric Patients: Creatinine/Cystatin C Ratio Performs Better Than Sarcopenia Index

Association between sarcopenia and cognitive impairment in the older people: a meta-analysis

Associations of Sarcopenia, Handgrip Strength and Calf Circumference with Cognitive Impairment among Chinese Older Adults.

Sarcopenia and cognitive impairment in older adults: Long-term prognostic implications based on the National Health and Nutrition Examination Survey (2011-2014)

The association between sarcopenia and functional disability in older adults